<DOC>
	<DOCNO>NCT02351115</DOCNO>
	<brief_summary>The purpose study determine whether people usually photosensitive epilepsy show reduction epileptic activity take single dose Staccato Alprazolam compare placebo .</brief_summary>
	<brief_title>Staccato Alprazolam Photoparoxysmal Response</brief_title>
	<detailed_description>The purpose study determine whether people usually photosensitive epilepsy show reduction epileptic activity take single dose Staccato Alprazolam compare placebo . People photosensitive epilepsy change electroencephalogram ( EEG ) show flash light . Three dose level Staccato Alprazolam compare placebo . This study also assess level sedation Staccato Alprazolam compare placebo .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Alprazolam</mesh_term>
	<criteria>Male female subject age 18 60 year , inclusive Body mass index ( BMI ) ≥18 ≤35 kg/m2 Able speak , read , understand English willing able provide write informed consent IRBapproved form initiation study procedures A diagnosis history photoparoxysmal response EEG without diagnosis epilepsy patient 02 concomitant antiepileptic drug At least 3 EEGs perform screen visit must reproducible IPSinduced photoparoxysmal response ( PPR ) EEG least 3 point frequency assessment scale least one eye condition In otherwise good general health determine complete medical history , physical examination , 12lead ECG , blood chemistry profile , hematology , urinalysis Female participant ( childbearing potential sexually active ) male participant ( sexually active partner childbearing potential ) agree use medically acceptable effective birth control method throughout study 1 week follow end study . Medically acceptable method contraception may use participant and/or his/her partner include abstinence , birth control pills patch , diaphragm spermicide , intrauterine device ( IUD ) , surgical sterilization , progestin implant injection . Prohibited method include : rhythm method , withdrawal , condoms alone , diaphragm alone History nonepileptic seizure ( e.g . metabolic , structural , pseudoseizures ) History seizure worsen response narrow spectrum drug An active CNS infection , demyelinate disease , degenerative neurological disease CNS disease deem progressive course study may confound interpretation study result Use 2 concomitant AEDs epilepsy treatment Subjects take know inhibitor inducer CYP3A , include carbamazepine Subjects history allergic reaction alprazolam benzodiazepine Treatment investigational drug within 30 day ( within 5 halflives investigational drug , &gt; 30 day ) Visit 2 A history within past 1 year drug alcohol dependence abuse Positive urine screen drug abuse Visit 1 Screening A history HIVpositivity Female subject positive pregnancy test screen prior test session breastfeed History acute narrow angle glaucoma , Parkinson 's disease , hydrocephalus , history significant head trauma Subjects current history asthma , chronic obstructive lung disease ( COPD ) , lung disease associate bronchospasm Subjects use medication treat airways disease , asthma COPD Subjects acute respiratory signs/symptoms ( e.g. , wheeze ) Clinically significant ECG abnormality include ( limit ) follow conduction abnormality dysrhythmias : atrial fibrillation , mean QTcF ( QT interval correct heart rate use Fridericia 's method ) interval &gt; 450 msec , ventricular rate &lt; 45 beats/min , second third degree AV block , leave bundle branch block , evidence prior myocardial infarction ( MI ) acute ischemia Hypotension ( systolic blood pressure ≤90 mm Hg , diastolic blood pressure ≤50 mm Hg ) , hypertension ( systolic blood pressure ≥140 mm Hg , diastolic blood pressure ≥100 mm Hg ) measure seat screen baseline Significant hepatic , renal , gastroenterologic , cardiovascular ( include ischemic heart disease congestive heart failure ) , endocrine , neurologic ( include history seizure stroke ) , hematologic disease Any disease condition , history , physical examination , laboratory abnormality investigator 's opinion , would present undue risk subject , may confound interpretation study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>